Modern Approaches to Anemia Management:
Current Models for Clinical and Practice Operation Success


Satellite Symposium at the 35th Annual Meeting of the American Society of Nephrology,
Philadelphia, PA, November, 2002
Introduction of Modern Approaches to Anemia Management
Brian J.G. Pereira, M.D.
The Hemoglobin Link to Adverse Patient Outcomes
Allan J. Collins, M.D.
A Picture of Clinical Success: An Opportunity to Improve Anemia Management
Mahesh Krishnan, M.D.
Questions and answers 
Access to this program is free but HDCN free zone registration is required.
Upon completion of this activity, participants should be able to:
  • Discuss the emerging medicare data that supports the correlation between anemia and morbidity, mortality, and hospitalization
  • Describe new data that further links anemia and cardiovascular disease
  • Discuss the advantages current therapies have on clinical practices
  • Describe the clinical and economic impact of anemia management in various pratice settings
Allan Collins, M.D.
Nephrology Analyst Services
Minneapolis, Minnesota

Mahesh Kirshnan, M.D.
Virginia Nephrology Group
Arlington, Virginia

Brian Pereira, M.D.
New England Healthcare Foundation
Boston, Massachusetts

Robert Toto, M.D.
University of Texas Southwestern Medical Center
Dallas, Texas
This satellite symposium is sponsored by an unrestricted educational grant from Amgen, Inc. This activity has been planned and produced in accordance with CME guidelines and policies. From a CME symposium held on November, 2002 at the The 35th Annual Meeting of the American Society of Nephrology in Philadelphia, PA. This symposium was approved by ASN. It was not part of the official ASN Annual Meeting.

The Postgraduate Institute for Medicine designates this activity for a maximum of 2 hours in category 1 credit toward the AMA Physician's Recognition Award.
Estimated time to complete activity: 2.0 hours
Posting date: January 2003
Review date: January, 2003
Expiration date: January, 2004

To obtain a statement of participation, you must complete the post-test by recording the best answer to each question in the answer key on the evaluation form, complete the evaluation form, and mail or fax the evaluation form with answer key to the Postgraduate Institute for Medicine.

Post-test and evaluation form is at this link, but you must listen to all talks from this symposium prior to completing the test

TARGET AUDIENCE :
This activity as been desighned to meet the educational needs of nephrologists involved in the treatment of patients with CKD and anemia.

STATEMENT OF NEED :
Chronic kidney disease affects 30-40 million Americans and is hence a major health care problem. Anemia of CKD is a preventable and treatable complication of CKD and is yet under recognized and under treated. Nephrologists should be sensitized to the above two facts and are the target audience for this message. This emerging information would be necessary to improve anemia management and consequently classical outcomes.

ACCREDITATION STATEMENT :
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Postgraduate Institute for Medicine and HealthVizion Communications. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

DESIGNATION STATEMENT(S) :
The Postgraduate Institute for Medicine designates this educational activity for a maximum of 2 hours in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity.

FACULTY DISCLOSURE STATEMENTS :
Postgraduate Institute for Medicine has a conflict of interest policy that requires course faculty to disclose any real or apparent commercial financial affiliations related to the content of their presentations/materials. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants.

Dr. Collins: Grants/Research Support: Amgen, Inc.
Dr. Krishman: Is a consultant and clinical investigator for AMGEN, Inc.
Dr. Pereira: Grants/Research Support: Amgen, Inc. Consultant: Amgen, Inc., Baxter. Speakers' Bureau: Amgen, Inc.
Dr. Toto: Grants/Research Support: Amgen

DISCLOSURE OF UNLABELED USE :
Faculty of this CME activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members will disclose to the audience any reference to an unlabeled or investigational use. The Postgraduate Institute for Medicine, HealthVizion Communications, and Amgen, Inc. do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

DISCLAIMER :
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.


This educational activity jointly sponsored by Postgraduate Institute for Medicine and Healthvizion Communications.
This educational activity is supported by an educational grant from Amgen, Inc.
This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies
BACK TO
TOPIC INDEX :